The Board denied service connection for MGUS and did not assign a rating for the Veteran's stroke, right lower extremity diabetic peripheral neuropathy, or left lower extremity diabetic peripheral neuropathy. The Veteran was granted TDIU.
The deciding factor: The evidence is insufficient to establish a current diagnosis of MGUS, and there are no ascertainable residuals from the stroke or diabetic peripheral neuropathy that warrant higher ratings.
- Claimed conditions
- Monoclonal gammopathy of undetermined significance (MGUS), Hemorrhagic stroke, Right lower extremity diabetic peripheral neuropathy, Left lower extremity diabetic peripheral neuropathy
- How they argued it
- Presumptive (no nexus needed)
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- August 27, 2024
- Citation
- A24050105
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation A24050105.
What this means for you
A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Denied
The Veteran's claim for a compensable rating for monoclonal gammopathy of undetermined significance (MGUS) is denied. The claim for service connection for bone cancer is also denied.
- Partly granted
The Veteran's 100% rating for hemorrhagic stroke is granted effective March 19, 2021. OSA and periodic limb movement syndrome are denied service connection. Pituitary mass remains under review.
- Remanded (sent back)
The Board has decided to remand the claims for MGUS and right knee disability due to a lack of examinations, which may provide additional evidence on the etiology of these conditions.
- Denied
The Veteran's service-connected monoclonal gammopathy of undetermined significance (MGUS) has not manifested to symptomatic multiple myeloma, and thus does not warrant a compensable rating.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.